Medtronic’s president of global regions set to retire in June

This audio is auto-generated. Please let us know if you have feedback.

Dive Brief:

  • Medtronic’s president of global regions, Rob ten Hoedt, will step down on June 28.
  • Ten Hoedt’s retirement, which Medtronic disclosed in a June 4 filing, comes more than 30 years after he joined the company.
  • Medtronic made ten Hoedt one of four regional leaders after it bought Covidien almost 10 years ago. Another of the four leaders, Bob White, left the company in April.

Dive Insight:

Ten Hoedt joined Medtronic as marketing manager for Western Europe’s neurological business in 1991. A series of promotions elevated ten Hoedt to the title of president of Medtronic Europe, Middle East, Africa and Canada. In that capacity, the executive led the creation of Medtronic’s hospital solutions business in Europe around 10 years ago.

Medtronic cited the formation of the hospital business as one of ten Hoedt’s achievements when the company made him one of four regional leaders as part of its takeover of Covidien. As the executive in charge of regions including Europe, ten Hoedt oversaw advances including the receipt of a CE mark for Medtronic’s Hugo surgical robot. 

The company took oversight of Canada away from ten Hoedt as part of the reorganization triggered by the Covidien takeover but later expanded his area of responsibility to cover the Americas, Europe, Middle East, Africa and Asia Pacific. As president of global regions, ten Hoedt played a role in the launch of the Medtronic Customer Experience Center in Singapore in 2022.

Ten Hoedt told Medtronic of his decision to retire on June 1 and is set to leave the company on June 28. The departure date is two months after White left the company. Medtronic made White president of the Asia-Pacific region when it reorganized as part of the Covidien takeover. Later, White became president of Medtronic’s medical surgical portfolio.

Medtronic eliminated that position when it exited the ventilator business. As part of the exit, the company combined its remaining patient monitoring and respiratory intervention businesses into a new acute care and monitoring unit.